Evidence map›Paper›PMID 42627362›Full record

ReviewJournal of Parkinson's disease2026

Global research synergy: Advancing fundamental Parkinson's research through international collaboration.

Jesus Gutierrez-Arratia, Paula Saffie-Awad, Artur F Schuh, Mario Cornejo-Olivas

Abstract readReview
In one paragraph

Review in Journal of Parkinson's disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jesus Gutierrez-ArratiaNeurogenetics Working Group, Universidad Cientifica del Sur, Lima, Peru.ORCID 0000-0003-4082-5966
Paula Saffie-AwadClínica Santa María, Santiago, Chile.ORCID 0000-0002-8056-365X
Artur F SchuhDepartment of Pharmacology, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.ORCID 0000-0002-8722-0908
Mario Cornejo-OlivasNeurogenetics Working Group, Universidad Cientifica del Sur, Lima, Peru.ORCID 0000-0001-6313-5680

Funding

NPGH LEADERs YR12: OBSSR (Greenberg, Ngwafong Mukere) & NIBIB (Lee)D43TW009345 · FIC · UNIVERSITY OF WASHINGTON · PI Dibyadyuti Datta, Chandy C. John · 2017 to 2026
$15.2M
FIC NIH HHS D43 TW009345
6 · The paper itself

Abstract

BackgroundThe remarkable advances achieved in Parkinson's disease (PD) research across clinical science, genetics, molecular and cellular mechanisms, disease modeling, pathophysiology, biomarkers, and therapeutics reflect not only scientific innovation but also the evolution of collaborative research. The field has transitioned from single-investigator observations and isolated institutional efforts to regional networks and global consortia that now drive many of the most important PD discoveries.ObjectiveTo review the evolution of collaborative research approaches in PD, examine barriers and challenges to global research synergy, and discuss potential solutions to promote equitable and impactful international collaboration.State of the Art and Future DirectionsKey challenges to global PD research include funding inequities, regulatory and data-sharing complexities, difficulties in standardization and generalizability, language barriers, limited interdisciplinary communication, unequal resource allocation, insufficient training opportunities, regional mistrust, and the need to address diverse cultural contexts. Successful international initiatives have demonstrated the value of shared databases, harmonized protocols, cross-border funding mechanisms, and synergistic multidisciplinary, multicultural, and multinational partnerships. Future efforts should be grounded in trust, transparency, ethical reciprocity, equitable governance, and meaningful stakeholder engagement, while prioritizing capacity building, workforce development, and sustainable training opportunities.ConclusionsAccelerating progress in PD research requires collaborative frameworks that integrate diverse populations, disciplines, institutions, and regions. Strengthening research infrastructure, community engagement, culturally grounded education, participant-centered research practices, and scientific leadership, particularly in low- and middle-income countries, will be essential to ensure that all populations can contribute to and benefit from scientific advances, fostering a more equitable and effective global PD research ecosystem.

Indexed as

global healthhealth equityinternational collaborationParkinson's diseaseresearch consortiatranslational research

Identifiers

PMID42627362
PMCPMC13498691

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.